Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab

Peer Review reports

Original Submission
15 Oct 2020	Submitted	Original manuscript
20 Dec 2020	Reviewed	Reviewer Report
31 Dec 2020	Reviewed	Reviewer Report
21 Jan 2021	Author responded	Author comments - Andrew Chandler
Resubmission - Version 2
21 Jan 2021	Submitted	Manuscript version 2
23 Feb 2021	Reviewed	Reviewer Report
25 Feb 2021	Reviewed	Reviewer Report
10 Mar 2021	Author responded	Author comments - Andrew Chandler
Resubmission - Version 3
10 Mar 2021	Submitted	Manuscript version 3
Publishing
18 Mar 2021	Editorially accepted
1 Apr 2021	Article published	10.1186/s12891-021-04182-z

Back to article page